Logotype for Birchtech Corp

Birchtech (BCHT) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Birchtech Corp

Q1 2026 earnings summary

13 May, 2026

Executive summary

  • Q1 2026 revenues rose 32% year-over-year to $4.24 million, driven by growth in water treatment and air business segments, with product sales up and licensing revenue down.

  • Completed uplisting to NYSE American and raised $16.44 million in gross proceeds, significantly strengthening liquidity and expanding the investor base.

  • Advanced enforcement of a $78 million patent infringement judgment, with collection efforts underway and post-judgment interest accruing, though realization remains uncertain due to ongoing appeals.

  • Launched SEA-IX nuclear-grade ion exchange resin, securing $1 million in initial orders and expanding the water solutions portfolio.

  • Appointed Michael Mioska as CFO in May 2026 to support growth and M&A activities.

Financial highlights

  • Product sales increased to $4.19 million from $2.68 million year-over-year, while licensing revenue dropped to $0 from $525,000.

  • Gross profit rose to $1.4 million from $1.2 million, with gross margin at approximately 33%.

  • Net loss narrowed to $1.3 million ($0.06 per share) from $1.7 million ($0.09 per share) year-over-year.

  • Adjusted EBITDA loss improved to $(1.0) million from $(1.2) million.

  • Cash balance at March 31, 2026 was $14.7 million, up from $2.2 million at year-end 2025, with no debt.

Outlook and guidance

  • Plans to collect on the $78 million judgment, convert more licensed utilities to recurring product supply, and advance offtake agreements for the first carbon rejuvenation facility.

  • Expects continued revenue growth in both air and water segments, with activated carbon sales comprising a larger share of total revenue.

  • Anticipates the water business, especially R&D and rejuvenation, to become a profit center in 2026.

  • Management expects sufficient liquidity for at least the next twelve months, supported by offering proceeds and anticipated revenues.

  • Positioned to capture growth in the water treatment sector, leveraging new laboratory investments and regulatory tailwinds.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more